JBS · JBS N.V.

JBS N.V. disclosed record financial performance for the full year 2025 during its 2026 Annual General Meeting held on April 30, 2026, with net revenue of US$86 billion reflecting a 12% increase over 2024 and net income of US$2 billion up 13%. The Chairman highlighted that this marked the highest revenue growth in company history at 15%, attributing the strong results primarily to contributions from Pilgrim’s Pride Corporation, JBS Australia, and Seara, underscoring the resilience of JBS's diversified protein platform across geographies. This performance supports robust margins and consistent execution, positioning the company to generate ongoing shareholder value. All agenda items received overwhelming approval with 94.98% of issued share capital represented, enabling simple majority passage. Key governance actions included adoption of the 2025 annual accounts audited by KPMG, discharge of directors for their 2025 duties, and reappointments of the full board including Executive Director Gilberto Tomazoni and Non-Executive Directors such as Chairman Jeremiah O’Callaghan and others. KPMG was reappointed as external auditor for 2026 following Audit Committee review. The board received authorizations for share issuances, limiting pre-emptive rights, Class A Common Share repurchases, and share cancellations, providing flexibility for capital management. No shareholder questions were raised, indicating strong alignment with investors.